ACI
RPRX icon

AMP Capital Investors’s Royalty Pharma RPRX Stock Holding History

AMP Capital Investors’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-13,425
Closed -$486K – 830
2021
Q3 		$486K Sell
13,425
-100
-0.7% -$3.89K ﹤0.01% 958
2021
Q2 		$554K Hold
13,525
– – ﹤0.01% 945
2021
Q1 		$590K Buy
+13,525
New +$641K ﹤0.01% 956

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SGA
Siguler Guff Advisers New York $56.1M AUM 46.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

AMP Capital Investors's RPRX Position: Q4 2021 in Review

AMP Capital Investors sold out of Royalty Pharma (RPRX) in Q4 2021, closing a stake of 13,425 shares — an estimated $486K sold.

AMP Capital Investors first reported a position in RPRX in Q1 2021 and held it in 3 quarters. The position peaked at $590K in Q1 2021. 266 funds tracked by Wall St. Rank hold RPRX as of Q4 2021.

  • AMP Capital Investors reported no remaining Royalty Pharma position as of Q4 2021 after selling out during the quarter.
  • AMP Capital Investors sold 13,425 Royalty Pharma shares in Q4 2021, an estimated $486K.
  • AMP Capital Investors first reported a position in Royalty Pharma in Q1 2021 and held it in 3 quarters.
  • AMP Capital Investors's Royalty Pharma position peaked at $590K in Q1 2021.
  • 266 funds tracked by Wall St. Rank held Royalty Pharma as of Q4 2021.

Based on AMP Capital Investors's 13F filing for Q4 2021, filed 14 Feb 2022.